Work

High Sensitivity NGS Analysis of MRD in CLL Patients Prospectively Treated with Ibrutinib Plus FCR (iFCR)

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-124305

Authors: Alexander R. Vartanov, Stacey M. Fernandes, Winnie I Nguy, Danielle M. Brander, Svitlana Tyekucheva, Alexandra Savell, Allison P. Jacob, Jon E. Arnason, Jeremy S. Abramson, Matthew S. Davids, Jennifer R. Brown

Institutions: Harvard University, Dana-Farber Cancer Institute, Duke Medical Center, Adaptive Biotechnologies (United States), Beth Israel Deaconess Medical Center, Massachusetts General Hospital

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986483558

Cites:

Cited by: 1

Related to: 10